Cancers by Anatomical Site
About Cancers by Anatomical Site
Cancers are often grouped by the organ where they start, such as the breast, lung, bowel, prostate, liver or stomach. Each site has its own risk factors, screening methods, treatments and specialist teams.
The Cancers by Anatomical Site session at Cancer Research 2027 covers research and care for site-specific cancers. It links closely with types of cancer, which groups cancers by the cells they start in.
Each organ has its own specialist team, screening methods and treatment guidelines. Breast, lung, bowel and prostate cancers are among the most common worldwide, while liver, stomach and nasopharyngeal cancers are especially important in Asia. Care works best when surgeons, oncologists, radiologists and nurses plan treatment together. This session brings these specialists into one room to share what works.
Key Topics in Cancers by Anatomical Site
• Breast cancer
• Lung cancer
• Colorectal and gastrointestinal cancers
• Liver, pancreatic and biliary cancers
• Prostate, kidney and bladder cancers
• Gynaecological cancers
• Head and neck cancers
• Thyroid and endocrine cancers
• Skin cancers
• Site-specific multidisciplinary care
Recent Advances in Cancers by Anatomical Site
Lung cancer screening with low-dose CT is expanding in many countries, and targeted drugs have improved outcomes for many patients. Screening and early detection, covered in cancer detection and diagnosis, remain key to better survival at many sites.
In Asia, liver, stomach and nasopharyngeal cancers are important research areas linked to infections and lifestyle factors explored in causes of cancer. Imaging advances from cancer imaging techniques are improving staging and treatment planning across all sites.
Targeted drugs and immunotherapy are now part of standard care for many site-specific cancers, such as lung and breast cancer. Organ-sparing surgery is helping more patients keep normal function after treatment. Survival rates for several common cancers have improved steadily over the past decade. Research is now focusing on closing the gaps in outcomes between countries and communities.
Who Should Attend the Cancers by Anatomical Site Session
• Site-specialist oncologists and surgeons
• Radiologists and pathologists
• Oncology nurses and specialist nurses
• Cancer researchers
• PhD students and early-career researchers
• Multidisciplinary team members
Why Present Your Research in Cancers by Anatomical Site
Cancer Research 2027 gives site-specific research an international audience. You can share results and learn from colleagues in cancer management and research working to improve care pathways. You can compare care pathways with teams from other health systems. Many of the best ideas for improving site-specific care come from these exchanges.
Frequently Asked Questions
Can I submit research on any organ-specific cancer?
Yes. Research on cancers of any anatomical site is welcome.
Is online presentation available?
Yes. Cancer Research 2027 is a hybrid event, so you can present in Singapore or online.
When is Cancer Research 2027?
Cancer Research 2027 runs from 8 to 10 March 2027 at Village Hotel Changi, Singapore.